Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 9, 2012 - Issue 6
Submit an article Journal homepage
712
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Efficacy of Indacaterol 75 μg Once-Daily on Dyspnea and Health Status: Results of Two Double-Blind, Placebo-Controlled 12-Week Studies

Mark H. GotfriedPulmonary Associates PA, Phoenix, Arizona, USACorrespondence[email protected]
,
Edward M. KerwinClinical Research Institute of Southern Oregon, PC, Medford, Oregon, USA
,
David LawrenceNovartis Horsham Research Centre, Horsham, West Sussex, UK
,
Cheryl LassenNovartis Horsham Research Centre, Horsham, West Sussex, UK
&
Benjamin KramerNovartis Pharmaceuticals, East Hanover, New Jersey, USA
Pages 629-636 | Published online: 28 Sep 2012

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Robert M Burkes & Ralph J Panos. (2020) Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease. Journal of Experimental Pharmacology 12, pages 589-602.
Read now
Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D’Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Don D. Sin & Darcy D. Marciniuk. (2019) Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 3:4, pages 210-232.
Read now
Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Darcy D. Marciniuk, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D'Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Denis E. O'Donnell & Don D. Sin. (2017) CTS position statement: Pharmacotherapy in patients with COPD—An update. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 1:4, pages 222-241.
Read now
James F Donohue, Keith A Betts, Ella Xiaoyan Du, Pablo Altman, Pankaj Goyal, Dorothy L Keininger, Jean-Bernard Gruenberger & James E Signorovitch. (2017) Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 367-381.
Read now
Denis E. O’Donnell, Katherine A. Webb, Ingrid Harle & J. Alberto Neder. (2016) Pharmacological management of breathlessness in COPD: recent advances and hopes for the future. Expert Review of Respiratory Medicine 10:7, pages 823-834.
Read now
Thomas M Siler, Craig F LaForce, Farid Kianifard, James Williams & Selwyn Spangenthal. (2014) Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 919-925.
Read now
Paschalis Steiropoulos, Kostas Archontogeorgis, Evangelia Nena & Demosthenes Bouros. (2014) New developments in the management of COPD: clinical utility of indacaterol 75 μg. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 1-7.
Read now
Andrea Rossi & Guido Polese. (2013) Indacaterol: a comprehensive review. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 353-363.
Read now

Articles from other publishers (6)

Margaret L. Campbell, DorAnne Donesky, Alexandra Sarkozy & Lynn F. Reinke. (2021) Treatment of Dyspnea in Advanced Disease and at the End of Life. Journal of Hospice & Palliative Nursing 23:5, pages 406-420.
Crossref
James F. Donohue, Paul W. Jones, Christian Bartels, Jessica Marvel, Peter D'Andrea, Donald Banerji, David G. Morris, Francesco Patalano & Robert Fogel. (2018) Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics 49, pages 11-19.
Crossref
Pierre-Olivier Girodet, Jean-Yves Jasnot, Vincent Le Gros, Laurent Decuypère, Weihua Cao & Gilles Devouassoux. (2017) Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis. Respiratory Medicine 128, pages 92-101.
Crossref
James B Geake, Eli J Dabscheck, Richard Wood-Baker & Christopher J Cates. (2015) Indacaterol, a once-daily beta 2 -agonist, versus twice-daily beta 2 -agonists or placebo for chronic obstructive pulmonary disease . Cochrane Database of Systematic Reviews 2017:3.
Crossref
Donald A. Mahler & Denis E. O'Donnell. (2015) Recent Advances in Dyspnea. Chest 147:1, pages 232-241.
Crossref
Jiangna Han, Lu Dai & Nanshan Zhong. (2013) Indacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trials. BMC Pulmonary Medicine 13:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.